School of Medicine

Wayne State University School of Medicine

Publications

Select Scientific Meeting Presentations and Peer-Reviewed Publications

- Khan O, Bao F, Shah M, et al. SWI based iron quantification does not correlate with deep gray-matter injury in MS: results of a pilot longitudinal study in RRMS. Presented at the 5th Joint Triennial Congress of the European and Americas Committees for the Treatment and Research in Multiple Sclerosis, October 19-22, 2011, Amsterdam. Multiple Sclerosis Journal 2011;17;S386

- Bhattacharya P, Bao F, Shah M, Ramesh G, Madhavan R, Khan O. Left Ventricular Dysfunction is associated with Cerebral Grey Matter Injury: Results of an in-vivo Brain MRI Segmentation Study. Presented at the International Stroke Conference, February 9-11, 2011, Los Angeles. Stroke 2011;42:e271

- Khan O, Bao F, Ramesh G, Santiago C, Bailey R. New biomarker marker for ALS: High-resolution pontine 1H-MRS. Presented at the 64rd Annual Meeting of the American Academy of Neurology, April 21-28, 2012, New Orleans. Neurology 2012

- Bernitsas E, Bao F, Shah M, Ramesh G, Mohammad W, Aronov R, Khan O. Spinal cord atrophy in multiple sclerosis and relationship to phenotype. Presented at the 64rd Annual Meeting of the American Academy of Neurology, April 21-28, 2012, New Orleans. Neurology 2012

- Lulu S, Bernitsas E, Bao F, Shah M, Caon C, Tselis A, Aronov R, Khan O. Radiologically Isolated Syndrome: Long-term follow up in 75 patients. Presented at the 64rd Annual Meeting of the American Academy of Neurology, April 21-28, 2012, New Orleans. Neurology 2012

- Dobson C*, Dore-Duffy P, Juhász C, Bao F, Santiago C, Khan O. Brain structural and functional abnormalities in multiple sclerosis. Presented at the Annual Meeting of the Consortium of Multiple Sclerosis Centers, May 30-June 2, 2012, San Diego. International Journal of MS Care 2012. (*Medical Student, Wayne State University)

- Khan O, Krstevska S, Bao F, Gorden V, Caon C, Shah M, George E. Novel exploratory study to examine the effect of rasagiline on tissue injury in the substantia nigra using multi-modal 3T advance MRI techniques in patients with Parkinson’s disease. Presented at the Movement Disorders Society 16th International Congress of Parkinson’s disease and Movement Disorders, Dublin, Ireland, June 17-21, 2012. Movement Disorders 2012.

- George E, Krstevska S, Bao F, Gorden V, Santiago C, Natalya Shneyder N, Caon C, Khan O. Novel Exploratory Study To Examine the Effect of Rasagiline on Tissue Injury in the Substantia Nigra Using Multi-Modal 3T Advanced MRI Techniques in Patients with Parkinson's Disease. Presented at the 65th Annual Meeting of the American Academy of Neurology, San Diego, March 16-23, 2013. Neurology 2013;80 (Meeting Abstracts 1: P02.082)

- Khan O, Kristevska S, George E, Gorden V, Bao F, Shah M, Thakore K, Caon C, Santiago C, Shneyder N. The effect of resagiline on tissue injury in Parkisnon’s disease. Movement Disorders. Abstract 182. Presented at the 17th International Congress of Parkinson’s disease and Movement Disorders. Movement Disorders Society. June 16-20, 2013, Sydney

- Khan OA, Shen Y, Caon C, Bao F, Ching W, Reznar M, Buccheister A*, Hu J, Latif Z, Tselis A, Lisak RP. Axonal Metabolic Recovery and Potential Neuroprotective Effect of Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis. Multiple Sclerosis 2005;6:646-651 (*graduate student)

- *Perumal J, **Zabad R, Caon C, MacKenzie M, Tselis A, Bao, F, Latif Z, Zak I, Lisak R, Khan, OA. Acute Transverse Myelitis with Normal Brain MRI: Long-term Risk of Clinically Definite MS. J Neurol 2008;255:89-93 (*postdoctoral fellow; **resident)

- Zivadinov R, Reder A, Filippi M, Minagar A, Stuve O, Lassman H, Racke M, Dwyer  M, Frohman E, Khan O. Mechanisms of Action of Disease-Modifying Agents and Brain Volume Changes in Multiple Sclerosis. Neurology 2008;71:136-144

- Khan OA, Shen Y, Bao F, Caon C, Tselis A, Latif Z, Zak I. Long-Term Study of Brain 1H-MRS Study in Multiple Sclerosis: Effect of Glatiramer Acetate Therapy on Axonal Metabolic Function and Feasibility of long-term 1H-MRS Monitoring in Multiple Sclerosis. J Neuroimaging 2008;18:314-319

- Haacke EM, Makki M Ge Y, Maheshwari M, Hu J, Selvan M, Wu Z, Latif Z, Garbern J, Khan O. Characterizing Iron Deposition in Multiple Sclerosis Lesions Using Susceptibility Weighted Imaging. JMRI 2009;29:537-544

- *Boster A, **Hreha S, Berger J, Bao F, Penmesta R, Tselis A, ***Endress C, Zak, *Perumal J, ; Caon C, Vazquez J, Tyler KL, Racke MK, Millis S, Khan OA. Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study. Arch Neurol 2009;66:593-599(*postdoctoral fellow; **graduate student; ***Medical Student)

- Khan O, Bao F, Shah M, Caon C, Tselis A, Bailey R. Effect of disease-modifying therapies on brain volume in relapsing-remitting multiple sclerosis: Results of a five-year brain MRI study. J Neurol Sci 2012;312:7-12.

- Bhattacharya P*, Bao F, Shah M, Ramesh G**, Madhavan R, Khan O. Left ventricular dysfunction is associated with cerebral grey matter injury: An in-vivo brain MRI segmentation study. J Neurol Sci 2012;321:111-113 (*Project started as post-doc Vascular Neurology fellow; **graduate student)